In Re Intelligroup Securities Litigation

527 F. Supp. 2d 262, 2007 U.S. Dist. LEXIS 83780, 2007 WL 3376743
District Court, D. New Jersey·Decided November 13, 2007·No. Civil Action No. 04-1980 (GEB)·Published·Cited by 60 cases

Opinion

OPINION

BROWN, Chief Judge.

This matter is before the Court on Defendants’ motions (collectively “Motions”) to dismiss the Plaintiffs’ Third Amended Consolidated Class Action Complaint (“Complaint”) pursuant to Federal Rules of Civil Procedure 9(b) and 12(b)(6), and the Private Securities Litigation Reform Act of 1995 (“Reform Act” or “PSLRA”), 15 U.S.C. §§ 78u-4, et seq. For the reasons discussed below, Defendants’ Motions are GRANTED, and Plaintiffs’ Complaint is DISMISSED WITH PREJUDICE.

TABLE OF CONTENTS

I. PROCEDURAL BACKGROUND...........................................271

II. FACTUAL BACKGROUND................................................272

III. JUDICIAL NOTICE.......................................................272

IV. PLEADING REQUIREMENTS OF A 10b-5 CLAIM.........................274

A. Elements of a 10b-5 Claim ............................................274

1. Elements Subject to Heightened Pleading Requirements.............275

*270 2. Elements Subject to Rule 8 Pleading Requirements..................277

B. Pleading a Class 10b-5 Claim..........................................279

C. Pleading a Derivative Claim Against Controlling Persons................280

V. PLEADING SPECIFIC ELEMENTS OF A 10b-5 CLAIM....................281

A. Pleading the “False and Misleading Statement” Element................281

1. Pleading an Affirmative Misrepresentation..........................281

2. Pleading Misrepresentation Based on Failure to Disclose............281

B. Pleading the “Scienter” Element ......................................282

1. Pleading Intentional or Recklessness State of Mind..................282

2. Pleading Scienter by Inference.....................................283

a. Inferring Scienter from Defendant’s “Motive and Opportunity” ...............................................283

b. Inferring Scienter from Circumstantial Evidence................285

i. Inferring Scienter from GAAP Violations...................285

ii. Inferring Scienter from SOX Certifications.................287

3. Pleading Scienter by Relying on Confidential Information ...........290

C. Pleading the “Materiality” Element....................................291

D. Pleading the “Reliance” Element......................................291

1. Two Methods to Plead Reliance....................................292

2. Pleading Reliance on Inferred Technical Facts......................293

E. Pleading the “Causation” Element.....................................295

VI. DISCUSSION.............................................................298

A. Transactional Causation..............................................298

1. Deficiencies Contained in Plaintiffs’ Second Complaint..............298

2. “Fraud-on-the-market” Allegations Based on Intelligroup’s Financials......................................................301

3. 2001 Period.......................................................302

4. 2004 Period.......................................................304

5. Periods Reflected in the Table .....................................305

a. Plaintiffs’ Allegations.........................................305

b. Legal Precedents Examining Financial Matters.................306

i. IPO Cases................................................306

ii. Basic v. Levinson.........................................309

iii. Other District Court Cases................................310

c. Financial Theories and Calculations............................311

6. Alternative Allegations of Reliance.................................316

B. Loss Causation.......................................................318

1. Relevant Facts....................................................319

a. Intelligroup’s Publications.....................................319

b. Chart of Intelligroup’s Stock Price .............................320

2. Deficiencies Contained in Plaintiffs’ Second Complaint..............321

3. Plaintiffs’ Instant Allegations......................................322

a. Interrelat ion-Among-the-Press-Release-Announcements

Claim......................................................322

b. Lack-of-Interrelation-Among-the-Announcements Claim........327

i. Marsden v. Select Med. Corp...............................327

ii. Other District Court Cases................................329

c. Miscellaneous Claims..........................................333

i. Contentions About Implied Disclosure......................334

ii. Contentions About the Post-Release Recovery..............337

C. Scienter..............................................................340

1. Motive and Opportunity...........................................340

2. Circumstantial Evidence...........................................342

a. Resignations as Evidence of Scienter ...........................343

i. Resignations of Defendants Valluri and Visco..............344

ii. Resignation of Intelligroup’s Auditor.......................348

b. Violations of GAAP as Evidence of Scienter.....................349

*271 c. SOX Certifications as Evidence of Scienter......................352

i. Impact of the Statements Made in the Restatement .........353

ii. The Fact of SOX Certifications............................355

iii. The Language of SOX Certifications.......................357

d. Undisclosed Witnesses.........................................358

i. UW-1....................................................359

ii. UW-2....................................................360

Free access — add to your briefcase to read the full text and ask questions with AI

In Re Intelligroup Securities Litigation, 527 F. Supp. 2d 262, 2007 U.S. Dist. LEXIS 83780, 2007 WL 3376743 (D.N.J. 2007).

527 F. Supp. 2d 262 (In Re Intelligroup Securities Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related